Press releases

All press releases Regulatory

Regulatory press release 2025-11-05

Interim Report Third Quarter 2025

Press release 2025-10-21

Xspray Pharma: FDA accepts New Drug Application for XS003 (nilotinib) for the treatment of CML – PDUFA date set for June 18, 2026

Regulatory press release 2025-10-10

Xspray Pharma’s Nomination Committee for the Annual General Meeting 2026

Regulatory press release 2025-10-08

Xspray Pharma provides update on the FDA process for Dasynoc – observations at contract manufacturer delay approval

Regulatory press release 2025-09-30

New number of shares and votes in Xspray Pharma after new share issue

All press releases

Latest report
Interim Report Q3 2025
Subscribe
Get our latest press releases and reports
Subscribe
Submit to our press releases and get an email every time we publish a press release or report on our website.
Type*
Reports
Press releases
E-mail*

Välj språk*
Swedish
English
When clicked on Send I agree that my personal information will be saved. Read more
Name
This field is for validation purposes and should be left unchanged.

Press contact

Jacob Nyberg, IR

+46 70-767 08 83

info@xspray.com

Media